MiMedx Group, Inc. Financials

Market Capitalization $1.29 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	15.42
Forward PE	28.35
Price to Sales TTM	$3.77
Price to Book MRQ	$7.13
Enterprise to Revenue	3.56
Enterprise to EBITDA	18.10

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	25.80%
Operating Margin	13.63%
Return on Assets TTM	18.38%
Return on Equity TTM	62.47%

Income Statement

Revenue TTM	$342,804,000
Revenue per Share TTM	$2.45
Quarterly Revenue Growth	2.90%
Gross Profit TTM	$285,798,016
EBITDA	$75,657,000
Net Income to Common TTM	$79,389,000
Diluted EPS TTM	$0.57
Quarterly Earnings Growth YoY	-5.10%

Balance Sheet

Total Cash MRQ	$88,801,000
Total Cash per Share MRQ	$0.60
Total Debt MRQ	$
Total Debt to Equity MRQ	10.51
Current Ratio MRQ	4.10
Book Value per Share MRQ	$1.23

Cash Flow

Operating Cash Flow TTM	$57,673,000
Levered Free Cash Flow TTM	$45,828,000

MDXG Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	146,946,000
Float Shares	108,975,312
Avg 10 Volume	529,480
Avg 30 Volume	None
Shares Short	4,476,346
Short Ratio	5.94
Short % of Shares	3.80%
% Held by Insiders	2.54%
% Held by Institutions	67.64%

Stock Price Summary

Beta	1.94
Fifty Two Week Low	$5.47
Fifty Two Week High	$10.14
Fifty Two Week Change	5.12%
Day 50 MA	$9.11
Day 200 MA	$7.29

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2008-04-02